Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW Conjugate Vaccine Immunogenicity and Safety in Adolescents
NCT04490018Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2021
- Primary completion
- May 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Mar 2021; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT04490018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04490018.